Cargando…
Metformin abrogates pathological TNF-α-producing B cells through mTOR-dependent metabolic reprogramming in polycystic ovary syndrome
B cells contribute to the pathogenesis of polycystic ovary syndrome (PCOS). Clinically, metformin is used to treat PCOS, but it is unclear whether metformin exerts its therapeutic effect by regulating B cells. Here, we showed that the expression level of tumor necrosis factor-alpha (TNF-α) in periph...
Autores principales: | Xiao, Na, Wang, Jie, Wang, Ting, Xiong, Xingliang, Zhou, Junyi, Su, Xian, Peng, Jing, Yang, Chao, Li, Xiaofeng, Lin, Ge, Lu, Guangxiu, Gong, Fei, Cheng, Lamei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270024/ https://www.ncbi.nlm.nih.gov/pubmed/35748536 http://dx.doi.org/10.7554/eLife.74713 |
Ejemplares similares
-
The role of B cells in immune cell activation in polycystic ovary syndrome
por: Ascani, Angelo, et al.
Publicado: (2023) -
IFN-γ mediates Paneth cell death via suppression of mTOR
por: Araujo, Alessandra, et al.
Publicado: (2021) -
A population of innate myelolymphoblastoid effector cell expanded by inactivation of mTOR complex 1 in mice
por: Tang, Fei, et al.
Publicado: (2017) -
High mTOR activity is a hallmark of reactive natural killer cells and amplifies early signaling through activating receptors
por: Marçais, Antoine, et al.
Publicado: (2017) -
mTOR, autophagy, and reprogramming
por: Tang, Bor Luen
Publicado: (2014)